{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:19:47Z","timestamp":1770041987761,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to investigate the incidence, remission and risk factors of non-alcoholic fatty liver disease (NAFLD) among a general population with a 6-year follow-up. In total, 691 individuals from the general population in Jilin, China aged 20\u201375 years participated in two independent cross-sectional surveys carried out in 2007 and 2013. After excluding patients with alcoholism, viral hepatitis and other liver diseases, 646 individuals were finally enrolled in our study. Of the 646 subjects, 512 did not have NAFLD at baseline, while 134 did. Of the 512 individuals without NAFLD at baseline, 188 (36.7%) developed NAFLD during the six-year follow-up period. The baseline body mass index (BMI, OR\u2009=\u20091.49, 1.36\u20131.64), high-density lipoprotein cholesterol level(HDL-C) (OR\u2009=\u20090.35, 0.16\u20130.76) and weight gain (OR\u2009=\u20091.22, 1.16\u20131.29) were independent predictors for NAFLD incidence. Of the 134 subjects with NAFLD at baseline, 33 (24.6%) had no evidence of NAFLD after 6 years. Males (OR\u2009=\u20094.85, 1.98\u201311.92) and baseline BMI levels (OR\u2009=\u20090.81, 0.70\u20130.94) were associated with NAFLD remission. Among the general population, the incidence of NAFLD mainly depended on baseline weight and weight gain. Subjects with mild baseline weights and male subjects were prone to NAFLD remission.<\/jats:p>","DOI":"10.1038\/s41598-018-25641-z","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T09:55:21Z","timestamp":1525859721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up"],"prefix":"10.1038","volume":"8","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumei","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuzhu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5187-7297","authenticated-orcid":false,"given":"Junqi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"25641_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"25641_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy, T., Oakley, F., Anstee, Q. M. & Day, C. P. Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. Annu Rev Pathol 11, 451\u2013496 (2016).","journal-title":"Annu Rev Pathol"},{"key":"25641_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363, 1341\u20131350 (2010).","journal-title":"N Engl J Med"},{"key":"25641_CR4","doi-asserted-by":"crossref","unstructured":"Pais, R. et al. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Aliment Pharmacol Ther (2017).","DOI":"10.1111\/apt.14261"},{"key":"25641_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","volume":"143","author":"M Hamaguchi","year":"2005","unstructured":"Hamaguchi, M. et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143, 722\u2013728 (2005).","journal-title":"Ann Intern Med"},{"key":"25641_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","volume":"60","author":"KC Sung","year":"2014","unstructured":"Sung, K. C., Wild, S. H. & Byrne, C. D. Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. J Hepatol 60, 1040\u20131045 (2014).","journal-title":"J Hepatol"},{"key":"25641_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.21827","volume":"46","author":"G Bedogni","year":"2007","unstructured":"Bedogni, G. et al. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 46, 1387\u20131391 (2007).","journal-title":"Hepatology"},{"key":"25641_CR8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jhep.2011.12.011","volume":"56","author":"S Zelber-Sagi","year":"2012","unstructured":"Zelber-Sagi, S. et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 56, 1145\u20131151 (2012).","journal-title":"J Hepatol"},{"key":"25641_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2014.08.041","volume":"62","author":"VW Wong","year":"2015","unstructured":"Wong, V. W. et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol 62, 182\u2013189 (2015).","journal-title":"J Hepatol"},{"key":"25641_CR10","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/liv.13478","volume":"37","author":"MA Niriella","year":"2017","unstructured":"Niriella, M. A. et al. Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans. Liver Int 37, 1715\u20131722 (2017).","journal-title":"Liver Int"},{"key":"25641_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jhep.2014.10.023","volume":"62","author":"G Marchesini","year":"2015","unstructured":"Marchesini, G. & Mazzotti, A. NAFLD incidence and remission: only a matter of weight gain and weight loss? J Hepatol 62, 15\u201317 (2015).","journal-title":"J Hepatol"},{"key":"25641_CR12","first-page":"389","volume":"74","author":"B Vos","year":"2011","unstructured":"Vos, B. et al. Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastroenterol Belg 74, 389\u2013394 (2011).","journal-title":"Acta Gastroenterol Belg"},{"key":"25641_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MAJ.0b013e3181812879","volume":"337","author":"HK Kim","year":"2009","unstructured":"Kim, H. K. et al. Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans. Am J Med Sci 337, 98\u2013102 (2009).","journal-title":"Am J Med Sci"},{"key":"25641_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/gut.2008.161885","volume":"58","author":"Y Chang","year":"2009","unstructured":"Chang, Y. et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 58, 1419\u20131425 (2009).","journal-title":"Gut"},{"key":"25641_CR15","doi-asserted-by":"publisher","first-page":"E568","DOI":"10.1152\/ajpendo.00560.2007","volume":"294","author":"J Erdmann","year":"2008","unstructured":"Erdmann, J. et al. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 294, E568\u2013575 (2008).","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"25641_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","volume":"91","author":"ZM Younossi","year":"2012","unstructured":"Younossi, Z. M. et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 91, 319\u2013327 (2012).","journal-title":"Medicine (Baltimore)"},{"key":"25641_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/hep.22575","volume":"49","author":"SA Harrison","year":"2009","unstructured":"Harrison, S. A., Fecht, W., Brunt, E. M. & Neuschwander-Tetri, B. A. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Hepatology 49, 80\u201386 (2009).","journal-title":"Hepatology"},{"key":"25641_CR18","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jhep.2005.06.008","volume":"43","author":"A Suzuki","year":"2005","unstructured":"Suzuki, A. et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 43, 1060\u20131066 (2005).","journal-title":"J Hepatol"},{"key":"25641_CR19","doi-asserted-by":"publisher","first-page":"e0166072","DOI":"10.1371\/journal.pone.0166072","volume":"11","author":"Z Zhou","year":"2016","unstructured":"Zhou, Z. et al. Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males. PLoS One 11, e0166072 (2016).","journal-title":"PLoS One"},{"key":"25641_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2016.05.026","volume":"65","author":"KC Sung","year":"2016","unstructured":"Sung, K. C. et al. Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver. J Hepatol 65, 791\u2013797 (2016).","journal-title":"J Hepatol"},{"key":"25641_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep41518","volume":"7","author":"J Wu","year":"2017","unstructured":"Wu, J. et al. Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013. Sci Rep 7, 41518 (2017).","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"25641_CR22","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc11-S011","volume":"34","author":"American Diabetes, A","year":"2011","unstructured":"American Diabetes, A. Standards of medical care in diabetes\u20132011. Diabetes Care 34(Suppl 1), S11\u201361 (2011).","journal-title":"Diabetes Care"},{"key":"25641_CR23","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian, A. V. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206\u20131252 (2003).","journal-title":"Hypertension"},{"key":"25641_CR24","first-page":"83","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou, B. F. & Cooperative Meta-Analysis Group of the Working Group on Obesity in, C. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15, 83\u201396 (2002).","journal-title":"Biomed Environ Sci"},{"key":"25641_CR25","unstructured":"Joint Committee for Developing Chinese guidelines on, P. & Treatment of Dyslipidemia in, A. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 35, 390\u2013419 (2007)."},{"key":"25641_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","volume":"12","author":"JG Fan","year":"2011","unstructured":"Fan, J. G. et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis 12, 38\u201344 (2011).","journal-title":"J Dig Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25641-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:15:50Z","timestamp":1671599750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25641"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25641-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7557"}}